Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CDK9 mRNA | affects expression | 21346803
|
C120275 |
2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone |
2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone inhibits the reaction [CDK9 protein binds to CCNT1 protein] | affects binding|decreases reaction | 17631934
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of CDK9 mRNA | decreases expression | 12419474
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CDK9 mRNA | affects expression | 17562736
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CDK9 mRNA | affects expression | 20382639
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of CDK9 mRNA | increases expression | 17720352
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of CDK9 mRNA | increases expression | 16934159
|
C415250 |
deferasirox |
deferasirox inhibits the reaction [CDK9 protein binds to CCNT1 protein] | affects binding|decreases reaction | 17631934
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of CDK9 mRNA | decreases expression | 12419474
|
C015329 |
lycopene |
lycopene results in decreased expression of CDK9 protein | decreases expression | 17337101
|
D037742 |
Nanotubes, Carbon |
Nanotubes, Carbon results in decreased expression of CDK9 mRNA | decreases expression | 15585362
|
C475587 |
olomoucine II |
olomoucine II results in decreased activity of CDK9 protein | decreases activity | 16003486
|
D011374 |
Progesterone |
Progesterone results in increased expression of CDK9 mRNA | increases expression | 16888808
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of CDK9 mRNA | decreases expression | 16705456
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CDK9 mRNA | increases expression | 15753651
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CDK9 protein | increases expression | 15753651
|
C066075 |
vanadium pentoxide |
vanadium pentoxide results in decreased expression of CDK9 mRNA | decreases expression | 17459161
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.62 | 15955085 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
4.10 | 10965797 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.87 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.08 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.34 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.41 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.61 | 16206674 16197459 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.37 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.27 | 15845082 15380490 15665606 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
2.11 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.11 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.11 | 16166294 16873071 16443354 |
MESH:D001991 |
Bronchitis |
|
vanadium pentoxide |
6.27 | 17459161 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.61 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.19 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.53 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.53 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.53 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.29 | 16051514 16096774 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.51 | 16936243 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.23 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.23 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.73 | 20889678 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.61 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.19 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.76 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.67 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.72 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.82 | 17551590 8800419 16925845 9142499 10589399 9211117 14991402 9125849 9664655 9224671 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.03 | 18551238 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.78 | 16285004 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.51 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.04 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
9.04 | 16177239 12705907 11287661 17906064 19739265 18071297 16081117 11739529 16109766 18713872 11461765 11743745 14986274 17562736 16781746 2444490 14725611 11529661 10915739 19164858 19416960 11834606 19085960 10774834 15968718 12153990 12540782 14550746 12958197 16227642 16485898 16393943 19420014 12392966 17522070 10663392 19923254 15619225 12594235 11421492 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
9.04 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
9.04 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.13 | 19426721 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.50 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.79 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.11 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.77 | 16134523 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.07 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.58 | 9664655 16938888 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.53 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.71 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.01 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.19 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.19 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.90 | 9664655 14991402 |
MESH:D015658 |
HIV Infections |
|
2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone |
8.21 | 17631934 |
MESH:D015658 |
HIV Infections |
|
deferasirox |
8.21 | 17631934 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.63 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.63 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.58 | 16778211 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.41 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.60 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.28 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.78 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.90 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.20 | 12587719 15629191 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.28 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
2.98 | 16705839 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.77 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.70 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.15 | 19075265 17712046 19642359 17368321 17339181 15748426 17107899 16766008 16788101 16331271 17361223 9834237 16891316 16140955 19035177 17506722 19029980 17217047 12679006 16935935 17301526 17649720 19225113 17294898 16823087 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.31 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.80 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.63 | 16610002 16611625 12587719 12969438 19784758 19014921 11587558 19460945 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.24 | 16871587 17185352 |
MESH:D008175 |
Lung Neoplasms |
|
vanadium pentoxide |
3.22 | 12376484 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.06 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
2.87 | 11408345 17203775 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.94 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.58 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.44 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.08 | 17596541 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.88 | 18551238 |
MESH:D009369 |
Neoplasms |
|
lycopene |
5.57 | 17051425 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.57 | 16946489 16594593 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.79 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.05 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.87 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.43 | 12819281 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.92 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.92 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.59 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.59 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.46 | 15976015 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
4.10 | 12065085 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.53 | 11550810 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
3.80 | 17337101 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.80 | 18760546 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.61 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.81 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.11 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.53 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
5.94 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.94 | 16467112 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.30 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.03 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.79 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.23 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.54 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
5.54 | 15537745 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.33 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.98 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.68 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.64 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.07 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.97 | 16287080 |